Baxter International Inc (BAX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BAX Annual Cash Flow →
From Baxter International Inc through Mar 31 2025, changes in Mar 31 2026's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
3 Months
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-15.00
Depreciation & amortization237.00
Amortization of Other Assets0.00
Impairment charges0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-95.00
Special charges0.00
Other longterm assets0.00
Share-based Compensation10.00
Prepaid expenses0.00
Restructuring charge0.00
Infusion Pump Charges-
Business Optimization Charges-
Asset Impairments And Other Charges-
Litigation Related Charge-
Available For Sale Securities Net Realized Gain Retained Shares Transactions-
Infusion Pump Reserve Charge Income-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash-4.00
Impairment Of Intangible Assets Excluding Goodwill-
Increase Decrease In Accrued Expenses And Other Current Liabilities-203.00
Income taxes29.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts Receivable152.00
Increase (Decrease) in Accounts Payable102.00
Accrued liabilities0.00
Post-retirement benefits expense0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.00
Other Working Capital0.00
Other Noncash Income (Expense)13.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-17.00
Discontinued operations2.00
Net Cash flow from Operating Activities213.00
Investing Activities
Capital Expenditures-137.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term investments acq.0.00
Proceeds from other investments0.00
Proceeds From Divestiture Of Businesses And Other-
Payment Proceeds From Divestiture Of Businesses And Other-
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities4.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-133.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock8.00
Payments of Distributions to Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-4,001.00
Net Realized Gains On Retained Share Transactions-
Stock Issued-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations1,968.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents2,019.00
Dividends paid to minority interests0.00
Dividends paid-5.00
Net Cash Flow from Financing Activities-11.00
Effect of exchange rate on cash flow-18.00
Discontinued operations0.00
Free Cash Flow76.00
Total Cash Flow51.00
4 historic quarters locked

Sign in to unlock the full Baxter International Inc cash flow history.

About Baxter International Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: bax-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-051118

Figures are derived from filed reports and may be restated. Historical data is subject to revision.